NCT07452120

Brief Summary

This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes. Seventy patients scheduled for elective hip arthroplasty under spinal anesthesia will be randomly assigned to receive either DIPB or SIFIB at the end of surgery. Postoperative pain scores, opioid consumption, motor block, and block-related complications will be evaluated over a 48-hour period. The study aims to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared to SIFIB, thereby contributing to safer and more comprehensive postoperative pain management in hip surgery patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Mar 2026Nov 2026

First Submitted

Initial submission to the registry

February 23, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

March 27, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

February 23, 2026

Last Update Submit

March 28, 2026

Conditions

Keywords

Deep Iliacus Plane BlockSuprainguinal Fascia Iliaca BlockHip ArthroplastyPostoperative PainRegional Anesthesia

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity

    Postoperative pain assessed using the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst pain imaginable) at rest and during movement following total hip arthroplasty.

    2, 4, 8, 16, 24, and 48 hours postoperatively

Secondary Outcomes (3)

  • Opioid consumption

    From the end of surgery to 48 hours postoperatively

  • Motor block

    4, 8, 16, 24, and 48 hours postoperatively

  • Pain during movement

    2, 4, 8, 16, 24, and 48 hours postoperatively

Study Arms (2)

Suprainguinal Fascia Iliaca Block (SIFIB)

EXPERIMENTAL

Participants randomized to this arm will receive an ultrasound-guided suprainguinal fascia iliaca compartment block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

Procedure: Suprainguinal Fascia Iliaca Block

Deep Iliacus Plane Block (DIPB)

EXPERIMENTAL

Participants randomized to this arm will receive an ultrasound-guided deep iliacus plane block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

Procedure: Deep Iliacus Plane Block

Interventions

Ultrasound-guided suprainguinal fascia iliaca compartment block performed at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

Suprainguinal Fascia Iliaca Block (SIFIB)

Ultrasound-guided deep iliacus plane block performed at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

Deep Iliacus Plane Block (DIPB)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged ≥18 years
  • ASA physical status I-III
  • Scheduled for elective primary total hip arthroplasty under spinal anesthesia
  • Ability to understand the study procedures and provide informed consent

You may not qualify if:

  • Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
  • Infection at the block application site
  • Hemodynamic instability
  • Known allergy to local anesthetics
  • Pre-existing significant neurological or motor deficits in the lower extremities
  • Cognitive impairment preventing pain assessment
  • Refusal to participate or inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sivas Numune Hospital

Sivas, Sivas, 58050, Turkey (Türkiye)

NOT YET RECRUITING

Sivas Numune Hospital

Sivas, Turkey (Türkiye)

RECRUITING

Related Publications (4)

  • Tulgar S, Ciftci B, Koyuncu B, Ahiskalioglu A, Alver S, Bilal B, Sakul BU, Otu E, Narayanan M, Alici HA. Ultrasound-guided Deep Iliacus Plane Block (DIPB): Cadaveric Evaluation and Pilot Retrospective Evaluation of Another Novel Fascial Plane Block for Hip Analgesia. Turk J Anaesthesiol Reanim. 2026 Feb 9;54(1):55-61. doi: 10.4274/TJAR.2025.252252. Epub 2026 Jan 7.

    PMID: 41498358BACKGROUND
  • Sekhon J, Jain R, Bansal K, Luthra N, Singh MR, Kumari B. Efficacy of Different Volumes of 0.2% Ropivacaine in Suprainguinal Fascia Iliaca Compartment Block for Multimodal Analgesia in Lower Limb Surgery. Cureus. 2023 Oct 12;15(10):e46894. doi: 10.7759/cureus.46894. eCollection 2023 Oct.

    PMID: 37954742BACKGROUND
  • Lee S, Hwang JM, Lee S, Eom H, Oh C, Chung W, Ko YK, Lee W, Hong B, Hwang DS. Implementation of the Obturator Nerve Block into a Supra-Inguinal Fascia Iliaca Compartment Block Based Analgesia Protocol for Hip Arthroscopy: Retrospective Pre-Post Study. Medicina (Kaunas). 2020 Mar 27;56(4):150. doi: 10.3390/medicina56040150.

    PMID: 32230895BACKGROUND
  • Saeaeh L, Chalacheewa T, Lerdwimonsak C, Phurikamonarunothai S. Comparison between combined suprainguinal fascia iliaca compartment block with intra-articular bupivacaine and suprainguinal fascia iliaca compartment block in total hip arthroplasty: randomized double blinded controlled trial. BMC Anesthesiol. 2025 Sep 29;25(1):461. doi: 10.1186/s12871-025-03345-y.

    PMID: 41023795BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Fatih BALCI

    Sivas Numune Hospital, Department of Anesthesiology and Reanimation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two parallel groups to receive either Deep Iliacus Plane Block (DIPB) or Suprainguinal Fascia Iliaca Block (SIFIB). Both interventions will be performed at the end of surgery, and outcomes will be assessed concurrently over a 48-hour postoperative period to compare analgesic efficacy, opioid consumption, motor blockade, and safety profiles between groups.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist physician

Study Record Dates

First Submitted

February 23, 2026

First Posted

March 5, 2026

Study Start

March 27, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations